Meir Ariel, retired from the IDF in 1993 as a Lieutenant Colonel after graduating from the Military Academy and serving as a battalion commander; served in the military reserves as the Golani Brigade’s Chief of Staff; managed a construction firm; joined A. Barak Security and lead it since 2007; co-founded Bazelet, first as a department of A. Barak and later as an independent firm fully dedicated to medical cannabis.
Prof. Aharon (Ari) Eyal is a retired Professor of Applied Chemistry from the Hebrew University of Jerusalem; author of 80 peer-reviewed articles and book chapters; was involved in more than 300 industrial projects in about 70 firms worldwide, including multinational, multi-billion dollar companies (20 years with the agri-giant Cargill, >$100 Billion); inventor of more than 200 patent families and patent applications; founded several startup companies.
Dr. Noa Raz holds a PhD in neuroscience from the Hebrew University of Jerusalem. She has authored about 30 papers in peer-reviewed scientific journals; inventor of more than 15 patent families. Worked 10 years in the Neurology department at Hadassah Hebrew University Medical center, conducted multiple scientific projects in the fields of neuroscience and neurology, incorporating a multi-disciplinary approach to understand mechanism and repair in neurological diseases. Her work at Bazelet is directed to evaluate the therapeutic role of selected cannabinoid-terpenes formulations to treat specific medical conditions.
Iso earned her B.Pharm from the Hebrew University of Jerusalem and MSc in molecular biology and human genetics from Sackler Faculty of Medicine, Tel-Aviv University. Iso is an experienced manager and head pharmacist in leading drugstore chain in Israel. She is specialized in management, training, customer care, sales and various aspects of pharmaceutical, cosmetics and retail business. At Bazelet, Iso is head of pharmaceutical division and product regulations and she is responsible for developing patient instruction methodology and continuing care protocols.
Dr. Danielle Hen-Shoval holds a PhD in neuropsychology from Bar -Ilan University. She explored novel cannabinoids compounds in treating mental illness; authored and contributed several papers in peer-reviewed scientific journals; Her work at Bazelet is managing the clinical studies and published its results . Also, she is responsible for the development of new drug delivery methods.
PhD in microbiology and molecular biology from Ben-Gurion University, over 30 years of experience in microbiology, molecular biology and project management. Was head of Microbiology field in the Israeli ministry of health. Published professional articles in his field of expertise. Vast experience in the field of microbiology, molecular biology, gene engineering, biochemistry, protein purification, and drug discovery projects. Experienced in running analytical and microbiological laboratories.